Universal Ibogaine Inc. IBOGF
Set alert
At close · Oct 30
- YTD
- -96.97%
- 1 year
- -98.55%
- Open
- 0.008
- Prev close
- 0.0001
- Mkt cap
- 31.29K
- Vol
- 9.50K
- Avg vol
- 179.10K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.008
- High
- 0.008
News
9 months ago thenewswire.com
Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
Calgary, AB – TheNewswire - January 19, 2026 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
10 months ago thenewswire.com
Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
Calgary, AB – TheNewswire - January 2, 2026 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
10 months ago thenewswire.com
Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
Calgary, AB – TheNewswire - December 18, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
11 months ago thenewswire.com
Universal Ibogaine advises further on application for Management Cease Trade Order
Calgary, AB – December 2, 2025 – TheNewswire – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
11 months ago thenewswire.com
Universal Ibogaine Advises of Filing Application for Management Cease Trade Order
Calgary, AB – TheNewswire - November 25, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered…
1 year ago thenewswire.com
Universal Ibogaine Provides Corporate Update
Calgary, AB – TheNewswire - October 28, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
1 year ago thenewswire.com
Universal Ibogaine Announces Board Changes
Calgary, AB – September 23, 2025 – TheNewswire - Universal Ibogaine Inc. (TSXV: IBO) OTC: IBOGF (the “Company”), The Universal Ibogaine Board of directors brings together expertise in healthcare ,…
1 year ago thenewswire.com
Universal Ibogaine Announces Results of the Annual Meeting of Shareholders
Calgary, AB – TheNewswire - September 1 4 , 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
1 year ago thenewswire.com
Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply
Calgary, Alberta, September 4, 2025 – TheNewswire - Universal Ibogaine Inc. (TSXV: IBO, in USA: IBOGF, in Germany FSE:JC4) (“ UI ” or the “ Company ) is pleased to announce its intention to file,…
1 year ago thenewswire.com
Universal Ibogaine advises of appointment of two new Board Members
Calgary, AB – September 3, 2025 – TheNewswire - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
1 year ago thenewswire.com
Universal Ibogaine advises of departure of CFO
Calgary, AB – TheNewswire - July 16, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
1 year ago thenewswire.com
Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors
Calgary, AB – TheNewswire - J uly 7, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized…
1 year ago thenewswire.com
Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order
Calgary, AB – TheNewswire - April 3, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction…
3 years ago proactiveinvestors.com
Universal Ibogaine says 2023 will be pivotal year for the company and Canadians seeking ibogaine treatment
Universal Ibogaine Inc (TSX-V:IBO) said it has laid the groundwork during 2022 to enter the new year positioned to advance its planned clinical trial involving semi-synthesized Ibogaine HCL (ibogaine…
3 years ago proactiveinvestors.com
Universal Ibogaine closes private placement, announces potential C$5M offering of convertible debt securities and shares
Universal Ibogaine Inc (TSX-V:IBO) said it has closed its previously announced non-brokered private placement of convertible notes for the aggregate principal amount of C$626,500. The company said…
3 years ago proactiveinvestors.ca
Universal Ibogaine forms advisory board in support of mission to deliver medicalized ibogaine-centered addiction care
Universal Ibogaine Inc (TSX-V:IBO) has formed an external advisory board as part of its strategic plans and mission to deliver medicalized ibogaine-centered addiction care and to undertake a planned…
4 years ago proactiveinvestors.com
Universal Ibogaine poised for offering to complete planned ibogaine-based clinical trial application
Universal Ibogaine Inc (TSX-V:IBO) (UI) reported it was set to carry out an offering of convertible debt securities with net proceeds to be used to complete its planned ibogaine-based clinical trial…
4 years ago proactiveinvestors.com
Universal Ibogaine says Kelburn addiction recovery clinic to reopen on October 17, 2022
Universal Ibogaine Inc (TSX-V:IBO) has said its research and development clinic in Winnipeg, the Kelburn Mental Health and Addiction Recovery Centre, is scheduled to reopen and commence business…
4 years ago proactiveinvestors.com
Universal Ibogaine targets October re-opening of Kelburn addiction treatment facility near Winnipeg
Universal Ibogaine Inc (TSX-V:IBO) said it is targeting early October for the re-opening of its Winnipeg addiction treatment facility, the Kelburn Recovery Centre, after it was closed in April due to…
4 years ago proactiveinvestors.com
Universal Ibogaine retains co-founder Shayne Nyquvest as capital markets advisor
Universal Ibogaine Inc (TSX-V:IBO) told investors that it has retained Shayne Nyquvest in a consulting role as capital markets advisor. Nyquvest, a co-founder of the company, has extensive capital…